Cardiac Prosthetic Devices Market, By Product (Heart valves, Tissue valve, Transcatheter valve, Mechanical valve, Pacemakers, Implantable pacemakers, and External pacemakers), By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4312
|
Published Date
August 2025
|
Pages
260
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Cardiac Prosthetic Devices Market size was valued at US$ 7,292.01 Million in 2024, expanding at a CAGR of 7.10% from 2025 to 2032.
Cardiac prosthetic devices are medical implants designed to replace or repair malfunctioning or damaged heart valves, helping to restore the proper function of the cardiovascular system, including the heart, arteries, and veins. These devices mimic the natural operation of healthy cardiovascular organs by ensuring proper blood flow within the heart, supporting ventricular filling and contractions, and ultimately enhancing overall heart performance. When used alongside cardiovascular monitoring systems, cardiac prosthetics contribute to improved surgical outcomes and advancements in surgical techniques. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, accounting for approximately 17.9 million deaths each year—highlighting the critical need for effective cardiac interventions such as prosthetic devices to improve patient outcomes worldwide.
Cardiac Prosthetic Devices Market- Market Dynamics
Rising Prevalence of Cardiovascular Diseases Fuels Market Growth
The rising prevalence of cardiovascular diseases is expected to drive significant growth in the cardiac prosthetic device market. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, including coronary artery disease, heart attacks, and stroke. Factors such as unhealthy lifestyles, high obesity rates, poor dietary habits, lack of physical activity, elevated stress levels, and an aging population all contribute to the increasing incidence of these conditions. Cardiac prosthetic devices play a crucial role in managing CVDs by supporting or replacing impaired heart functions or components.
For example, data from January 2024 published by the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK suffer from heart and circulatory diseases—around 4 million men and 3.6 million women. These conditions account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or roughly 480 deaths per day—equivalent to one death every three minutes. This alarming statistic underscores the urgent need for effective cardiac interventions, which is expected to propel market growth.
Cardiac Prosthetic Devices Market- Segmentation Analysis:
The Global Cardiac Prosthetic Devices Market is segmented on the basis of Product, and Region.
The cardiac prosthetic devices market is segmented into seven product categories: Heart Valves, Tissue Valves, Transcatheter Valves, Mechanical Valves, Pacemakers, Implantable Pacemakers, and External Pacemakers. Among these, mechanical valves are projected to be one of the largest revenue-generating subsegments in 2025. Their growth is supported by the use of durable raw materials, such as advanced polymers, which provide patients with long-lasting, lifelong solutions. These materials help reduce clinical complications commonly associated with mechanical valves, thereby decreasing the need for repeated surgical interventions. According to the U.S. National Library of Medicine (NLM), mechanical heart valves have a 90% success rate in reducing the need for reoperations within 15 years, highlighting their reliability and contribution to market expansion.
Cardiac Prosthetic Devices Market- Geographical Insights
From a geographical perspective, North America is expected to dominate the cardiac prosthetic devices market in 2025, driven by the rising prevalence of cardiovascular diseases and an increasingly aging population. The demand for cardiac prosthetics like heart valves, pacemakers, and implantable defibrillators is growing as heart-related conditions become more widespread. The region benefits from a robust healthcare infrastructure, strong reimbursement policies, and significant investments in research and development focused on innovative and minimally invasive prosthetic devices. The Centers for Disease Control and Prevention (CDC) reports that nearly 697,000 people in the U.S. die each year from heart disease, emphasizing the critical need for advanced cardiac prosthetic technologies.
The Asia Pacific region is anticipated to witness lucrative growth during the forecast period, primarily due to a significant rise in the prevalence of cardiovascular diseases, which is driving higher mortality rates. Increasing urbanization, lifestyle changes, and limited access to early diagnosis contribute to the growing disease burden in this region. Consequently, there is a substantial opportunity for key market players to address the unmet needs of the affected population by introducing innovative cardiac prosthetic solutions. According to the World Health Organization (WHO), cardiovascular diseases account for over 30% of all deaths in Asia Pacific countries, underscoring the urgent demand for enhanced medical interventions and device accessibility in this market.
Cardiac Prosthetic Devices Market- Competitive Landscape:
The cardiac prosthetic devices market is highly competitive, with leading medical device companies such as Medtronic, Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, and St. Jude Medical, Inc. offering a broad portfolio of products, including mechanical and biological heart valves, as well as transcatheter valve replacement systems. These companies focus heavily on innovation, prioritizing minimally invasive procedures, advancements in transcatheter aortic valve replacement (TAVR) technology, and patient-specific implant designs. Key competitive strategies include strategic partnerships, obtaining regulatory approvals, and launching new products. Additionally, the growing prevalence of cardiovascular diseases and improved access to cardiac care in regions like Asia-Pacific and Latin America are driving market expansion and intensifying competition.
Recent Developments:
- In April 2025, Abbott announced positive clinical trial results from its TACTIC-AF study, which evaluated the efficacy of its novel dual-chamber leadless pacemaker system. The encouraging interoperability data has expedited regulatory approvals in the US and Europe, signaling strong acceptance of next-generation leadless pacing technologies with expanded clinical applications.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CARDIAC PROSTHETIC DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Medtronic, Inc
- Edwards Lifesciences Corporation
- Boston Scientific Corporation
- St. Jude Medical, Inc
- Siemens Healthcare GmbH
- Abbott Vascular
- Sorin Group.
- Others
GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Heart valves
- Tissue valve
- Stented tissue valve
- Stentless tissue valve
- Transcatheter valve
- Mechanical valve
- Pacemakers
- Implantable pacemakers
- Single-Chamber Battery Pacemaker
- Dual-Chamber Battery Pacemaker
- Triple-Chamber Battery Pacemaker
- External pacemakers
GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Cardiac Prosthetic Devices Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cardiac Prosthetic Devices Market Snippet by Product
2.1.2. Cardiac Prosthetic Devices Market Snippet by Country
2.1.3. Cardiac Prosthetic Devices Market Snippet by Region
2.2. Competitive Insights
3. Cardiac Prosthetic Devices Key Market Trends
3.1. Cardiac Prosthetic Devices Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cardiac Prosthetic Devices Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cardiac Prosthetic Devices Market Opportunities
3.4. Cardiac Prosthetic Devices Market Future Trends
4. Cardiac Prosthetic Devices Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cardiac Prosthetic Devices Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Cardiac Prosthetic Devices Market Landscape
6.1. Cardiac Prosthetic Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cardiac Prosthetic Devices Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Heart valves
7.1.3. Tissue valve
7.1.3.1. Stented tissue valve
7.1.3.2. Stentless tissue valve
7.1.4. Transcatheter valve
7.1.5. Mechanical valve
7.1.6. Pacemakers
7.1.7. Implantable pacemakers
7.1.7.1. Single-Chamber Battery Pacemaker
7.1.7.2. Dual-Chamber Battery Pacemaker
7.1.7.3. Triple-Chamber Battery Pacemaker
7.1.8. External pacemakers
8. Cardiac Prosthetic Devices Market– By Geography
8.1. Introduction
8.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
8.2. North America
8.2.1. Overview
8.2.2. Cardiac Prosthetic Devices Key Manufacturers in North America
8.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.2.5. U.S.
8.2.5.1. Overview
8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.2.5.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.2.6. Canada
8.2.6.1. Overview
8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.2.6.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Cardiac Prosthetic Devices Key Manufacturers in Europe
8.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.5. Germany
8.3.5.1. Overview
8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.5.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.6. UK
8.3.6.1. Overview
8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.6.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.7. France
8.3.7.1. Overview
8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.7.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.8. Italy
8.3.8.1. Overview
8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.9. Spain
8.3.9.1. Overview
8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.9.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.10. The Netherlands
8.3.10.1. Overview
8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.10.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.11. Sweden
8.3.11.1. Overview
8.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.11.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.12. Russia
8.3.12.1. Overview
8.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.12.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.13. Poland
8.3.13.1. Overview
8.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.13.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.14. Rest of Europe
8.3.14.1. Overview
8.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Cardiac Prosthetic Devices Key Manufacturers in Asia Pacific
8.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.5. China
8.4.5.1. Overview
8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.5.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.6. India
8.4.6.1. Overview
8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.7. Japan
8.4.7.1. Overview
8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.7.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.8. South Korea
8.4.8.1. Overview
8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.8.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.9. Australia
8.4.9.1. Overview
8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.9.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.10. Indonesia
8.4.10.1. Overview
8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.10.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.11. Thailand
8.4.11.1. Overview
8.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.12. Philippines
8.4.12.1. Overview
8.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.12.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.13. Rest of APAC
8.4.13.1. Overview
8.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.13.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5. Latin America (LATAM)
8.5.1. Overview
8.5.2. Cardiac Prosthetic Devices Key Manufacturers in Latin America
8.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5.5. Brazil
8.5.5.1. Overview
8.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.5.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5.6. Mexico
8.5.6.1. Overview
8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.6.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5.7. Argentina
8.5.7.1. Overview
8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.7.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5.8. Colombia
8.5.8.1. Overview
8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.8.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5.9. Rest of LATAM
8.5.9.1. Overview
8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.9.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6. Middle East and Africa (MEA)
8.6.1. Overview
8.6.2. Cardiac Prosthetic Devices Key Manufacturers in Middle East and Africa
8.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.5. Saudi Arabia
8.6.5.1. Overview
8.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.5.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.6. UAE
8.6.6.1. Overview
8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.6.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.7. Israel
8.6.7.1. Overview
8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.7.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.8. Turkey
8.6.8.1. Overview
8.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.8.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.9. Algeria
8.6.9.1. Overview
8.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.9.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.10. Egypt
8.6.10.1. Overview
8.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.10.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.11. Rest of MEA
8.6.11.1. Overview
8.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.11.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9. Key Vendor Analysis- Cardiac Prosthetic Devices Industry
9.1. Competitive Benchmarking
9.1.1. Competitive Dashboard
9.1.2. Competitive Positioning
9.2. Company Profiles
9.2.1. Medtronic, Inc
9.2.2. Edwards Lifesciences Corporation
9.2.3. Boston Scientific Corporation
9.2.4. St. Jude Medical, Inc
9.2.5. Siemens Healthcare GmbH
9.2.6. Abbott Vascular
9.2.7. Sorin Group.
9.2.8. Others
10. 360 Degree AnalystView
11. Appendix
11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
